Yoshida Yoko

Phase Ⅰ/Ⅱ, Double-Masked, Randomized, Vehicle-Controlled Study of H-1337 Ophthalmic Solution for Glaucoma and Ocular Hypertension.

The H-1337 ophthalmic solution showed clinically and statistically significant ocular hypotensive activity and was well tolerated, with a relatively low incidence of hyperemia. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Vault Decay Prediction Formula for Posterior Chamber Phakic Intraocular Lens With Central Hole Implantation: A 10-Year Follow-Up Study.

ICL V4c implantation demonstrates excellent long-term safety, efficacy, and predictability. Moreover, vault behavior-a key safety indicator-can be reliably predicted using a novel mathematical model.